Metraipolis › archive › dc_799393facbe3
Evaluation of a New Methylimidazole-Containing Thiosemicarbazone as a Cu+/Cu2+-Targeting Ligand in the Context of Alzheimer's Disease — Europe PMC PMID:41312650
- Source
- Europe PMC (en)
- Original
- https://europepmc.org/article/MED/41312650
- DOI
- 10.1002/chem.202502754
- License (as archived)
- solo-consultazione
- Archived
- 2026-11-08T04:35:39.296Z
- SHA-256 of the archived text
603c2c683edc652e036b1c0180c7d92fc8c3e9b7a09f17a1023fbf40226ede3a- Stable URL of this page
https://metraipolis.com/documento/dc_799393facbe3
How to cite
Evaluation of a New Methylimidazole-Containing Thiosemicarbazone as a Cu+/Cu2+-Targeting Ligand in the Context of Alzheimer's Disease — Europe PMC PMID:41312650 — Europe PMC (en), https://europepmc.org/article/MED/41312650 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_799393facbe3 (Metraipolis archive dc_799393facbe3, sha256 603c2c683edc652e036b1c0180c7d92fc8c3e9b7a09f17a1023fbf40226ede3a)
BibTeX
@misc{dc799393facbe3,
title = {Evaluation of a New Methylimidazole-Containing Thiosemicarbazone as a Cu+/Cu2+-Targeting Ligand in the Context of Alzheimer's Disease — Europe PMC PMID:41312650},
howpublished = {Europe PMC (en)},
url = {https://europepmc.org/article/MED/41312650},
note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_799393facbe3; sha256 603c2c683edc652e036b1c0180c7d92fc8c3e9b7a09f17a1023fbf40226ede3a},
year = {2026}
}Archived text
The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41312650. Agents can read the archived copy with the MCP tool read_document.